Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Smoking Cessation Health Center

Font Size

Study Links Chantix to Suicide Risk, but FDA Disagrees

Researchers Say Anti-Smoking Drug Is Linked to Risk of Suicide; FDA and Drugmaker Disagree
WebMD Health News
Reviewed by Laura J. Martin, MD

Nov. 3, 2011 -- Just over a week after federal health officials released a report finding no evidence of an increased risk of serious psychiatric problems in users of the anti-smoking drug Chantix, a new study comes to the opposite conclusion.

Investigators who were the first to link the drug to suicidal behavior and depression say the new research suggests that Chantix may be too risky to use as a first treatment for smoking cessation and should only be used when other treatments have failed.

Representatives of FDA and Pfizer, the drug's manufacturer, strongly disagree with the new study findings.

Stronger Warning Needed?

The researchers found that 90% of all reported suicides related to anti-smoking treatments from 1998 to 2010 involved Chantix, even though the drug has only been on the market in the U.S. for about four years.

"We believe this drug is not suitable for use as a first choice for people who are trying to stop smoking," study researcher Thomas J. Moore tells WebMD. Moore is a senior scientist with Safe Medicine Practices, an independent drug safety research group.

The researchers say that use of Chantix was eight times more likely to result in suicidal behavior or depression than use of nicotine-replacement gums, patches, lozenges, and inhalers.

They are asking the FDA to revise its labeling for Chantix to show this increased risk. But an FDA official is calling the researchers' conclusions misleading.

The new study was published online this week and appears in the November issue of PLoS One.

1 | 2 | 3

Today on WebMD

hands breaking a cigarette
Is quitting cold turkey an effective method?
14 tips to get you through the first hard days.
smoking man
Surprising impacts of tobacco on the body.
cigarette smoke
What happens when you kick the habit?

Filtered cigarettes
an array of e cigarettes
human heart
Woman experiencing withdrawal symptoms

man smoking cigarette
no smoking sign
Woman ashing cigarette in ashtray
chain watch